According to Renub Research United States Artificial Intelligence (AI) in Pharmaceutical Market is entering a period of rapid expansion, driven by the urgent need to accelerate drug development, reduce research costs, and enable precision medicine. The market is projected to grow from USD 0.97 million in 2025 to USD 16.78 million by 2034, reflecting an exceptional compound annual growth rate (CAGR) of 37.23% from 2026 to 2034. This strong growth trajectory is supported by rising pharmaceutical R&D investments, major advances in machine learning and generative AI models, and increasing pressure on drug developers to bring therapies to market faster and more cost-effectively. The United States, with its mature pharmaceutical ecosystem and advanced digital infrastructure, stands at the forefront of AI adoption in life sciences.
Download Free Samp…U.S. AI in Pharma Market Analysis by Technology & Application, States 2026–34
United States Artificial Intelligence in Pharmaceutical Market Size & Forecast 2026–2034
Read more